David A. Siegel Procept Bio Robotics Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 90,000 shares of PRCT stock, worth $5.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
90,000
Previous 26,700
237.08%
Holding current value
$5.23 Million
Previous $2.14 Million
238.91%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$299 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$203 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$102 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$86.6 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$70.1 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.59B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...